文献速递分子诊断

牛津Nanopore PromethION自适应采样用于强直性肌营养不良1型DMPK重复扩增定量的初步研究

A pilot study on the application of Oxford Nanopore PromethION sequencing with adaptive sampling for DMPK repeat expansion sizing in myotonic dystrophy type 1.
PubMed 文献 · Clin Chim Acta · 2026-05-28

该初步研究评估了牛津Nanopore PromethION测序结合自适应采样对DMPK基因CTG重复扩增进行定量的可行性。正常等位基因定量一致,参考品和部分临床样本的扩增等位基因估计与既往正交结果一致,但扩增等位基因覆盖度仍不稳定,低reads观察限制部分样本的置信度。

要点

  • 自适应采样PromethION测序可对DMPK重复扩增进行初步定量。
  • 正常等位基因定量与参考品、EQA和临床样本结果一致。
  • 扩增等位基因覆盖度不稳定,常规诊断前需提升覆盖度并扩大验证。

核心结论

  • 自适应采样PromethION测序是DMPK重复扩增定量的可行初步方法,但需改善覆盖度并扩大临床验证后方可用于常规诊断。

主要发现

  • 将每张flow cell的多重样本数降至2份可改善中位扩增等位基因覆盖度。
  • 正常等位基因定量在参考品、外部质量评估和临床样本间一致,参考品和部分临床样本的扩增等位基因估计与既往正交结果一致。
  • 单分子reads提供的重复大小分布与样本内变异性一致,但扩增等位基因覆盖度仍可变,低reads观察限制部分样本的置信度。

临床怎么用

  • 可作为DMPK重复扩增定量的初步探索性方法,但尚不能替代常规诊断流程。

局限性

  • 扩增等位基因覆盖度仍不稳定,低reads观察限制部分样本的置信度。
  • 需改善覆盖度并开展更大规模的临床验证后方可常规用于诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myotonic dystrophy type 1 (DM1) is caused by a CTG repeat expansion in the DMPK gene, but conventional polymerase chain reaction and Southern blot-based workflows provide limited resolution for large expansions and somatic mosaicism. This pilot study evaluated Oxford Nanopore PromethION sequencing with adaptive sampling for DMPK repeat expansion sizing. Fifteen samples, including Coriell reference materials, European Molecular Genetics Quality Network external quality assessment materials, and clinical samples, were sequenced across seven adaptive-sampling runs using native barcoding. DMPK repeat-spanning reads were aligned to the reference genome and summarized at read level. Sequencing runs generated a median of 38.9 gigabases of data and 56.2 million reads, with median DMPK repeat-locus coverage of 49×. Reducing multiplexing to two samples per flow cell improved median expanded-allele coverage. Normal allele sizing was concordant across reference, external quality assessment, and clinical samples, and expanded-allele estimates in reference materials and selected clinical samples were consistent with prior orthogonal results. Single-molecule reads also provided repeat-size distributions consistent with intra-sample variability. However, expanded-allele coverage remained variable, and low-read observations limited confidence for some samples. These findings support adaptive-sampling PromethION sequencing as a feasible pilot approach for DMPK repeat expansion sizing, while indicating that improved coverage and larger clinical validation are needed before routine diagnostic implementation.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Lau NKC, Tong TTY, Chong YK, et al. A pilot study on the application of Oxford Nanopore PromethION sequencing with adaptive sampling for DMPK repeat expansion sizing in myotonic dystrophy type 1. Clin Chim Acta. 2026. PMID: 42214742. doi:10.1016/j.cca.2026.121118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。